Please wait while the formulary information is being retrieved.
CLINDAMYCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE)
- Acne vulgaris
- Bacterial vaginosis
- Evoclin Topical Foam
- Clindamycin Vaginal Cream
- Clindamycin Topical Solution
- Clindamycin Topical Gel
- Clindamycin Topical Foam
- Clindamycin Phosphate Topical Swab
- Clindamycin Phosphate Topical Solution
- Clindamycin Lotion
- Clindacin P Topical Swab
- Clindacin Etz Topical Swab
- Cleocin Vaginal Cream
- Cleocin T Topical Gel
- Cleocin T Solution
- Cleocin T Lotion
- By Indication
1 % topical foam
- Apply to the affected area(s) after washing with a mild soap by topical route once daily
clindamycin 2 % vaginal cream
- Insert 1 applicatorful (100 mg) by vaginal route once daily at bedtime
1 % topical solution
- Apply a thin layer to the affected area(s) by topical route 2 times per day
clindamycin 1 % topical gel
- Apply a thin layer to the affected area(s) by topical route 2 times per day
clindamycin 1 % topical foam
- Apply to the affected area(s) after washing with a mild soap by topical route once daily
1 % topical swab
- Apply a thin layer to the affected area(s) by topical route 2 times per day
1 % topical solution
- Apply a thin layer to the affected area(s) by topical route 2 times per day
clindamycin 1 % lotion
- Apply a thin layer to the affected area(s) by topical route 2 times per day
1 % topical swab
- Apply a thin layer to the affected area(s) by topical route 2 times per day
1 % topical swab
- Apply a thin layer to the affected area(s) by topical route 2 times per day
2 % vaginal cream
- Insert 1 applicatorful (100 mg) by vaginal route once daily at bedtime
1 % topical gel
- Apply a thin layer to the affected area(s) by topical route 2 times per day
1 % solution
- Apply a thin layer to the affected area(s) by topical route 2 times per day
1 % lotion
- Apply a thin layer to the affected area(s) by topical route 2 times per day
Acne rosacea
- Apply a thin layer to the affected area(s) by topical route 2 times per day
Acne vulgaris
- Apply a thin layer to the affected area(s) by topical route 2 times per day
- Apply to the affected area(s) after washing with a mild soap by topical route once daily
Bacterial vaginosis
- Insert 1 applicatorful (100 mg) by vaginal route once daily at bedtime
- Insert 1 applicatorful (100 mg) by vaginal route once daily at bedtime for 3 days
- Insert 1 applicatorful (100 mg) by vaginal route once daily at bedtime for 7 days
- typhoid vaccine
- Vivotif Berna Vaccine
Contraindicated
- None
Severe
Moderate
- None
- Crohn's disease
- Ulcerative colitis
Contraindicated
- Clostridium difficile infection
Severe
Moderate
- Atopic dermatitis
CLINDAMYCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE)
- Acne vulgaris
- Bacterial vaginosis
- Erythema
- Genital organ pruritus
- Pruritus of skin
- Vaginitis
- Abnormal desquamation
- Dry skin
- Skin irritation
- Vulvovaginal candidiasis
More Frequent
Severe
Less Severe
- Abdominal pain with cramps
- Headache disorder
- Nausea
- Skin rash
- Urticaria
- Vomiting
- Headache disorder
- Oily skin
- Stinging of skin
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Anaphylaxis
- Bloody diarrhea
- Candidiasis
- Clostridium difficile infection
- Diarrhea
- Edema
Less Severe
- Abnormal vaginal bleeding
- Acute abdominal pain
- Constipation
- Contact dermatitis
- Diarrhea
- Dizziness
- Dysgeusia
- Dyspepsia
- Dysuria
- Epistaxis
- Erythema
- Flatulence
- Gram-negative folliculitis
- Halitosis
- Hyperthyroidism
- Menstrual disorder
- Ocular pain
- Skin rash
- Upper respiratory infection
- Urinary tract infection
- Urticaria
- Vaginal discharge
- Vertigo
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Clindamycin (Topical)
Safety and efficacy not established age < 12 years.
Safety and efficacy not established.
- 1 Day – 12 Years
- Safety and efficacy not established age < 12 years.
- 1 Day – 18 Years
- Safety and efficacy not established age < 12 years.
Clindamycin (vaginal)
Safety and efficacy not established age < 12 years.
Safety and efficacy not established.
- 1 Day – 12 Years
- Safety and efficacy not established.
- 1 Day – 18 Years
- Safety and efficacy not established.
Clindamycin (top, Vag)
- Severity Level:
2
- Additional Notes: Insuff human and animal data available
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
No Known Risk
Clindamycin (top, Vag)
Avoiding nipple area application will reduce infants risk for diarrhea
| General | Excretion Potential | Effect on Infant | Notes |
| No known risks; does not adversely affect lactation | Unknown | Not known; no or inclusive data | Avoiding nipple area application will reduce infants risk for diarrhea |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Acne vulgaris | |
| L70.0 | Acne vulgaris |
| Bacterial vaginosis | |
| N76.0 | Acute vaginitis |
| 0-9 | A-Z |
|---|---|
| L70.0 | Acne vulgaris |
| N76.0 | Acute vaginitis |
Formulary Reference Tool